Concepedia

Michael E. Kelly

ME

153

Publications

12.3K

Citations

52

H-Index

1942

Active since

Affiliations

Dalhousie University(Current)

University of Birmingham

University of Liverpool

University College London

Edinburgh Royal Infirmary

Michael E. Kelly is an author at Dalhousie University specializing in medicine, neuroscience, and pharmacology.

ORCID

Top concepts

Publications per year

1942–2024

153

Publications

153

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister et al. · New England Journal of Medicine · 2012 · 1.1K citations · Full text

Cannabidiol is a negative allosteric modulator of the cannabinoid CB <sub>1</sub> receptor

Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly et al. · British Journal of Pharmacology · 2015 · 960 citations · Full text

Cannabis in painful HIV-associated sensory neuropathy

Donald I. Abrams, Cheryl A. Jay, Starley B. Shade et al. · Neurology · 2007 · 589 citations

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

, , +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Rows per page

1–5 of 153